Trade Mark Journal No.2026/017 24 April 2026

UK00004367251 31 March 2026 (5)

Mark 1

Image for mark UK00004367251_1of5 RX ENHANCED

Mark 2

Image for mark UK00004367251_2of5

Mark 3

Image for mark UK00004367251_3of5

Mark 4

Image for mark UK00004367251_4of5

Mark 5

Image for mark UK00004367251_5of5
Class 5
Human allograft tissue; tissue-regenerative pharmaceutical preparations; implants comprising living tissue; biological tissue cultures for medical purposes; implants for guided tissue regeneration; tissues impregnated with pharmaceutical lotions; surgical implants comprised of living tissues; implantable materials for use in guided tissue regeneration; surgical implants grown from stem cells [living tissues]; implantable textile material to encourage the growth of tissue; biological preparations for medical purposes; denatured biological tissue; denatured human tissue; implants comprising of dead tissue; dead human tissue; surgical implants comprised of denatured human tissue; implantable tissue derived from human tissue.

Synergy Medical Technologies Ltd